Development Of the VAMPCT Score for Predicting Mortality in CKD Patients with COVID-19

Chaofan Li1, Yue Niu1, Xinyan Pan2

  • 1Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Medical Devices and Integrated Traditional Chinese and Western Drug Development for Severe Kidney Diseases, Beijing Key Laboratory of Digital Intelligent TCM for the Prevention and Treatment of Pan-vascular Diseases, Key Disciplines of National Administration of Traditional Chinese Medicine (zyyzdxk-2023310), Beijing 100853, China.

Insights

A new machine learning score, VAMPCT, accurately predicts COVID-19 mortality in chronic kidney disease (CKD) patients. This tool aids in identifying high-risk individuals for better clinical management.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Artificial Intelligence in Medicine

Background:

  • Patients with chronic kidney disease (CKD) face elevated mortality risk from coronavirus disease 2019 (COVID-19).
  • Current methods for identifying high-risk CKD patients with COVID-19 are suboptimal.
  • There is a need for improved clinical tools to predict mortality in this vulnerable population.

Purpose of the Study:

  • To develop and validate a machine learning (ML)-based score for predicting acute COVID-19 mortality in CKD patients.
  • To identify key clinical and laboratory factors associated with mortality in this cohort.
  • To create a user-friendly scoring system for clinical application.

Main Methods:

  • Prospective enrollment of 219 CKD inpatients with COVID-19 from December 2022 to January 2023.
  • Feature selection using least absolute shrinkage and selection operator (LASSO) and stepwise methods.
  • Development and comparison of ML models including logistic regression, SVM, random forest, and XGBoost.
  • Construction of a predictive score based on logistic regression using identified key factors.

Main Results:

  • The study included 219 CKD patients with a high mortality rate of 25.1%.
  • The Support Vector Machine (SVM) model demonstrated strong predictive performance (AUC 0.946).
  • The developed VAMPCT score, incorporating COVID-19 vaccination status, age, monocyte percentage, prothrombin activity, cardiac troponin T, and total bilirubin, achieved a high AUC of 0.960 for predicting 3-month mortality.

Conclusions:

  • Machine learning models show excellent performance in predicting 3-month mortality for CKD patients with COVID-19.
  • The VAMPCT score offers a clinically practical and accurate method for risk stratification.
  • This tool can aid clinicians in managing high-risk CKD patients during the COVID-19 pandemic.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
101
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
83
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
105
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
78